Kaplan Ma

3.4k citations
200 papers · 2.6k · 2 hit papers · h-index 22

Impact in

  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies
    • Inflammatory Biomarkers in Disease Prognosis
    • Breast Cancer Treatment Studies

Papers in

    • Lung Cancer Diagnosis and Treatment 16
    • Occupational and environmental lung diseases 14
    • Lung Cancer Treatments and Mutations 9
    • Gastric Cancer Management and Outcomes 8
    • Brain Metastases and Treatment 7
    • Colorectal Cancer Treatments and Studies 12
    • HER2/EGFR in Cancer Research 8

Kaplan Ma

184 papers receiving 2.5k citations

Kaplan Ma's Hit Papers

First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743 2022 · 211 citations
2110+1+3Years since publication100200300400500

Peers

Kaplan Ma
Comparison fields: 5 of 98
  • Oncology 859
  • Cancer Research 371
  • Pulmonary and Respiratory Medicine 671
  • Microbiology 7
  • Gastroenterology 52
Replace Cheng‐Ping Yu with:
Cheng‐Ping Yu Taiwan
Shinichi Ishioka Japan
Sally Naji Temraz Lebanon
Caimiao Wei United States
Alain Jonathan Gelibter Italy
Eiji Sunami Japan
Gianluigi Ferretti Italy
Faruk Taş Türkiye
Dino Amadori Italy
Tadashi Mio Japan
Kaplan Ma relative to Cheng‐Ping Yu Taiwan Cheng‐Ping Yu's profile →
Citations per field
00.5×2×4×6×7×
Cheng‐Ping Yu · 1×
Citations per year

Countries citing papers authored by Kaplan Ma

Since Specialization
Citations

This map shows the geographic impact of Kaplan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaplan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaplan Ma more than expected).

Fields of papers citing papers by Kaplan Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaplan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaplan Ma. The network helps show where Kaplan Ma may publish in the future.

Co-authors

The 25 scholars most cited alongside Kaplan Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kaplan Ma Line = papers co-authored together Kaplan Ma links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 200 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
Hit paper breakdown →
2021589
2
First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743
Hit paper breakdown →
2022211
3 201986
4 200682
5
Amphomycin, a new antibiotic.
195371
6 201063
7 201157
8 201150
9 201241
10 200736
11 201332
12 202030
13 201129
14 201227
15 201327
16 201327
17 201327
18 201326
19
The use of triacetyloleandomycin in chronic infectious asthma.
200023
20 201223

About Kaplan Ma

Kaplan Ma is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Pharmacology and Otorhinolaryngology, having authored 200 papers that have together received 2.6k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (16 papers), Occupational and environmental lung diseases (14 papers), Breast Cancer Treatment Studies (13 papers), Colorectal Cancer Treatments and Studies (12 papers), Lung Cancer Treatments and Mutations (9 papers), HER2/EGFR in Cancer Research (8 papers), Gastric Cancer Management and Outcomes (8 papers) and Brain Metastases and Treatment (7 papers). The work is most often cited by research in Oncology (859 citations), Cancer Research (371 citations), Pulmonary and Respiratory Medicine (671 citations), Microbiology (7 citations) and Gastroenterology (52 citations). Kaplan Ma has collaborated with scholars based in Türkiye, United States and France. Frequent co-authors include Abdurrahman Işıkdoğan, Zeynep Oruç, Mehmet Küçüköner, Ali̇ İnal, Zuhat Urakçı, Velı Berk, Bernard Heinemann, Süleyman Buyukberber, Mustafa Beneklı and Irving R. Hooper. Their work appears in journals such as Annals of Oncology, Journal of Cancer Research and Clinical Oncology, Journal of Chemotherapy, Medical Oncology and Photodiagnosis and Photodynamic Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact